RECRUITING

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Despite major technological advances, management of type one diabetes mellitus (T1D) remains suboptimal, putting millions of people at risk for immediate and long-term complications. After meals, a mismatch between carbohydrate absorption rate and insulin action typically leads to alternating periods of hyper- and hypoglycemia. A conceptually promising approach to control both problems is dietary carbohydrate restriction to reduce postprandial blood glucose changes and insulin needs. In a prior survey study, the investigators documented exceptional glycemic control (HbA1c 5.67%) and low acute complication rates among 316 children and adults with T1D consuming a very-low-carbohydrate diet. To test the feasibility of this approach, the investigators will conduct a randomized-controlled feeding study involving 32 adults and adolescents with T1D. Participants will be randomized to receive a very low carbohydrate vs. standard carbohydrate diet. Participants will be in the study for 12 weeks and receive all their meals by meal delivery.They will share continuous glucose monitoring data with the study team and be in close communication to adjust insulin doses as needed. All participants will have a screening visit, an individual or group education session, and 3 study visits to evaluate diabetes control and metabolic health. Some of these visits will have a fasting blood draw. Two of the visits will also comprise additional metabolic studies to assess glucagon response and brain function during hypoglycemia by magnetic resonance imaging (MRI). Participants will have IV catheters placed and receive IV insulin to drop blood glucose levels to 50 mg/dl for up to 30 minutes. The primary outcome will be HbA1c change from baseline. Secondary outcomes include detailed measures of glycemic variability, metabolic health, and quality of life.

Official Title

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

Quick Facts

Study Start:2020-01-03
Study Completion:2024-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03710928

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Males and females with T1D for at least 1 year
  2. * Age 18 to 40 years
  3. * Tanner stage ≥ IV
  4. * BMI 18.5-35 kg/m2
  5. * Stable glycemic control (HbA1c 6.5-9%)
  6. * Use of a continuous glucose monitor (CGM)
  7. * Use of an insulin pump
  8. * Attendance of at least 1 diabetes care visit over the past 12 months (including virtual)
  1. * Ketoacidosis or severe hypoglycemia with seizure or coma in the past 6 months
  2. * Dietary restrictions or intolerances that are incompatible with the planned food deliveries, e.g. celiac disease, gastroparesis, certain food allergies
  3. * Following a weight-loss or otherwise restrictive diet
  4. * Vigorous exercise \>2 hours on \>3 days a week
  5. * History of an eating disorder or at risk for eating disorder, assessed by the Eating Disorders Diagnostic Scale (EDDS)
  6. * Major medical illness or use of medications other than insulin and metformin that could interfere with metabolic or glycemic variables
  7. * Significant psychiatric illness
  8. * Smoking, use of recreational drugs, or excessive alcohol consumption
  9. * Pregnancy or breastfeeding
  10. * Anemia
  11. * For participants who undergo MRI:
  12. 1. Standard MRI exclusion criteria
  13. 2. Irregular menses
  14. 3. Use of psychotropic medication other than SSRIs or other mild antidepressant or anxiety medications (unless these medications are safe to be held for several days to allow for the acquisition of MRI data)

Contacts and Locations

Study Contact

Belinda Lennerz, MD PhD
CONTACT
8572183896
belinda.lennerz@childrens.harvard.edu
Svetlana Azova, MD
CONTACT
6179196675
svetlana.azova@childrens.harvard.edu

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Boston Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-03
Study Completion Date2024-07-31

Study Record Updates

Study Start Date2020-01-03
Study Completion Date2024-07-31

Terms related to this study

Keywords Provided by Researchers

  • very low carbohydrate diet
  • nutrition
  • ketogenic diet
  • ketosis
  • nutritional ketosis
  • metabolism
  • metabolic health

Additional Relevant MeSH Terms

  • Type1diabetes